OC 66 - VTE prophylaxis in surgical patients

Moderator(s)

• 

  Timothy Hoberstorfer, MD

  PhD student
  Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna
  Vienna, Wien, Austria
• 

  Walter Ageno, MD

  Professor
  University of Varese
  Bellinzona, Ticino, Switzerland

Presentations:

• 14:45 – 15:00 ICT

  Venous Thromboembolism Prophylaxis After Surgery For Hip Fracture: A Survey of Physician Practices from the HIPSTER study group.
  

  Presenting Author: Federico Germini – McMaster University

  Co-Author: Deborah Siegal, MD MSc FRCPC – University of Ottawa and Ottawa Hospital Research Institute

  Co-Author: Alejandro Daniel Godoy – McMaster University

  Co-Author: Noel Chan – McMaster University

  Co-Author: Flavia Borges – McMaster University

  Co-Author: Dennis Christopher – Queens University

  Co-Author: Kerstin de Wit – Queen's University

  Co-Author: James Douketis – McMaster University

  Co-Author: John Eikelboom – McMaster University

  Co-Author: Peter Gross – McMaster University

  Co-Author: Rick Ikesaka – McMaster University

  Co-Author: Maura Marcucci – McMaster University

  Co-Author: Sameer Parpia – McMaster University

  Co-Author: Lehana Thabane – McMaster University

  Co-Author: Vinai Bhagirath – McMaster University

  Co-Author: Jeffrey I. Weitz – McMaster Univeristy
• 15:00 – 15:15 ICT

  Characterizing the Relationship between Milvexian Exposure, Efficacy, and Safety in Total Knee Replacement Patients to Support Milvexian Phase 3 Dose Selection.
  

  Presenting Author: Wangda Zhou, PHD – Clinical Pharmacology and Pharmacometrics, Johnson and Johnson Innovative Medicine

  Co-Author: Emily Bozenhardt – Clinical Pharmacology and Pharmacometrics, Johnson and Johnson Innovative Medicine

  Co-Author: Samira Merali – Clinical Pharmacology and Pharmacometrics, Bristol Myers Squibb

  Co-Author: Peter Zannikos – Clinical Pharmacology and Pharmacometrics, Johnson and Johnson Innovative Medicine

  Co-Author: Hyunmoon Back – Clinical Pharmacology and Pharmacometrics, Bristol Myers Squibb

  Co-Author: Antoinette Ajavon-Hartmann – Clinical Pharmacology and Pharmacometrics, Bristol Myers Squibb

  Co-Author: John Strony – Global Clinical Development of CVM, Johnson and Johnson Innovative Medicine

  Co-Author: Alexei Plotnikov – Global Clinical Development of CVM, Johnson and Johnson Innovative Medicine

  Co-Author: Alistair Lindsay – Global Clinical Development of CVM, Johnson and Johnson Innovative Medicine

  Co-Author: Navin Goyal – Clinical Pharmacology and Pharmacometrics, Johnson and Johnson Innovative Medicine

  Co-Author: Mahesh N. Samtani – Clinical Pharmacology and Pharmacometrics, Johnson and Johnson Innovative Medicine
• 15:15 – 15:30 ICT

  A model-based meta-analysis leveraging total knee replacement (TKR) data for selection of the milvexian dose for a phase 3 study in participants with atrial fibrillation.
  

  Co-Author: Gregory E. Alexander – Janssen Research & Development, LLC

  Co-Author: Matthew Zierhut – CERTARA

  Co-Author: Fei Chen – Janssen Research & Development, LLC

  Co-Author: EunYoung Suh – Janssen Research & Development, LLC

  Co-Author: Peter Zannikos – Clinical Pharmacology and Pharmacometrics, Johnson and Johnson Innovative Medicine

  Co-Author: Alexei Plotnikov – Global Clinical Development of CVM, Johnson and Johnson Innovative Medicine

  Co-Author: Navin Goyal – Clinical Pharmacology and Pharmacometrics, Johnson and Johnson Innovative Medicine

  Presenting Author: Chandni Valiathan, PhD – Janssen Research & Development, LLC
• 15:30 – 15:45 ICT

  Pharmacotherapy for venous thromboprophylaxis following total hip or knee arthroplasty: a systematic review and network meta-analysis
  

  Co-Author: Bryan Song Jun Yong – Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore

  Co-Author: Ryan Ruiyang Ling – Yong Loo Lin School of Medicine, National University of Singapore, National University Health System, Singapore, Singapore

  Co-Author: Ruiqi Li – Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore

  Co-Author: Jane Wenjin Poh – Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.

  Co-Author: Chuen Seng Tan – Saw Swee Hock School of Public Health, National University of Singapore, National University Health System, Singapore

  Co-Author: Sean Wei Loong Ho – Department of Orthopaedic Surgery, Tan Tock Seng Hospital, Singapore

  Co-Author: Bram Rochwerg – Department of Medicine, Division of Critical Care, McMaster University, Hamilton, ON, Canada

  Co-Author: Roopen Arya – King’s Thrombosis Centre, Department of Haematological Medicine, King’s College Hospital Foundation NHS Trust, London, UK

  Co-Author: Kollengode Ramanathan – Cardiothoracic Intensive Care Unit, National University Heart Centre, National University Hospital, Singapore, Singapore.

  Presenting Author: Bingwen Eugene Fan, MBBS, MRCP, MMED – Department of Haematology, Tan Tock Seng Hospital, Singapore
• 15:45 – 16:00 ICT

  Antithrombotic prophylaxis following inferior vena cava replacement with cryopreserved aortic homograft for primary leiomyosarcoma: a cohort study
  

  Presenting Author: Juri Alessandro Giannotta, Medical Doctor – Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy

  Co-Author: Marco Capecchi – Division of Hematology, Gruppo Ospedaliero Moncucco - Clinica Moncucco, Lugano, Switzerland

  Co-Author: Stefano Radaelli – Sarcoma Service, Surgical Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy

  Co-Author: Laura Benuzzi – General Surgery Residency Program, University of Milan, Milan, Italy

  Co-Author: Federica Del Coco – General Surgery Residency Program, University of Milan, Milan, Italy

  Co-Author: Alessandro Gronchi – Sarcoma Service, Surgical Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy

  Co-Author: Marco Fiore – Sarcoma Service, Surgical Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy

  Co-Author: Paolo Bucciarelli – Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy